Cancer clinical trial - Vedanta Biosciences, Inc. - VE800-001

Status:

Open

ClinicalTrials.gov:

NCT04208958

Phase 1 Study of VE800 and Nivolumab in Patients With Selected Types of Advanced or Metastatic Cancer

Drug

VE800-001 + nivolumab

Trial Type

Interventional

Phase

Phase 1

Condition

Melanoma

Keywords

Melanoma | Vedanta Biosciences | VE800-001